Cargando…
The emerging role of probiotics as a mitigation strategy against coronavirus disease 2019 (COVID-19)
COVID-19 is an acute respiratory infection accompanied by pneumonia caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has affected millions of people globally. To date, there are no highly efficient therapies for this infection. Probiotic bacteria can interact with the gu...
Autores principales: | Mirzaei, Rasoul, Attar, Adeleh, Papizadeh, Saher, Jeda, Ali Salimi, Hosseini-Fard, Seyed Reza, Jamasbi, Elaheh, Kazemi, Sima, Amerkani, Saman, Talei, Gholam Reza, Moradi, Pouya, Jalalifar, Saba, Yousefimashouf, Rasoul, Hossain, Mohammad Akhter, Keyvani, Hossein, Karampoor, Sajad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980799/ https://www.ncbi.nlm.nih.gov/pubmed/33745067 http://dx.doi.org/10.1007/s00705-021-05036-8 |
Ejemplares similares
-
Correction to: The emerging role of probiotics as a mitigation strategy against coronavirus disease 2019 (COVID‑19)
por: Mirzaei, Rasoul, et al.
Publicado: (2021) -
Overview of the current promising approaches for the development of an effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine
por: Mirzaei, Rasoul, et al.
Publicado: (2020) -
The emerging role of microRNAs in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
por: Mirzaei, Rasoul, et al.
Publicado: (2021) -
The emerging role of exosomal miRNAs as a diagnostic and therapeutic biomarker in Mycobacterium tuberculosis infection
por: Mirzaei, Rasoul, et al.
Publicado: (2021) -
Highly Synergistic Effects of Melittin With Vancomycin and Rifampin Against Vancomycin and Rifampin Resistant Staphylococcus epidermidis
por: Mirzaei, Rasoul, et al.
Publicado: (2022)